126 related articles for article (PubMed ID: 9033605)
1. [Bladder neoplasms and cyclophosphamide. Apropos pf 3 cases amd review of the literature].
Alexandre J; Lévy V; Hunault M; Bazarbachi A; Delmer A; Rio B; Zittoun R
Bull Cancer; 1996 Nov; 83(11):945-50. PubMed ID: 9033605
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.
Talar-Williams C; Hijazi YM; Walther MM; Linehan WM; Hallahan CW; Lubensky I; Kerr GS; Hoffman GS; Fauci AS; Sneller MC
Ann Intern Med; 1996 Mar; 124(5):477-84. PubMed ID: 8602705
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.
Stillwell TJ; Benson RC
Cancer; 1988 Feb; 61(3):451-7. PubMed ID: 3338015
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the urinary bladder in patients receiving cyclophosphamide.
Wall RL; Clausen KP
N Engl J Med; 1975 Aug; 293(6):271-3. PubMed ID: 1138180
[TBL] [Abstract][Full Text] [Related]
5. [Cancer of the bladder after cystitis due to cyclophosphamide. Apropos of a case].
Dore B; Grange P; Aubert J
J Urol (Paris); 1989; 95(7):427-31. PubMed ID: 2687398
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinoma of the bladder associated with cyclophosphamide.
Dale GA; Smith RB
J Urol; 1974 Nov; 112(5):603-4. PubMed ID: 4214370
[No Abstract] [Full Text] [Related]
7. [Tumors of the upper urothelium and cyclophosphamide: presentation of a case and review of the literature].
de Castro Barbosa F; Rosell Costa D; Agüera Fernández L; Isa Kroon WA; Sánchez de la Muela P; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
Arch Esp Urol; 1991 Dec; 44(10):1149-51. PubMed ID: 1817448
[TBL] [Abstract][Full Text] [Related]
8. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty EJ; Van Leeuwen FE; Lynch CF; Hagenbeek A; Stovall M; Banks PM; Adami J
J Natl Cancer Inst; 1995 Apr; 87(7):524-30. PubMed ID: 7707439
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
Pedersen-Bjergaard J; Ersbøll J; Hansen VL; Sørensen BL; Christoffersen K; Hou-Jensen K; Nissen NI; Knudsen JB; Hansen MM
N Engl J Med; 1988 Apr; 318(16):1028-32. PubMed ID: 3352696
[TBL] [Abstract][Full Text] [Related]
10. Mucinous (colloid) carcinoma of urinary bladder following long-term cyclophosphamide therapy for Waldenstrom's macroglobulinemia.
Siddiqui A; Melamed MR; Abbi R; Ahmed T
Am J Surg Pathol; 1996 Apr; 20(4):500-4. PubMed ID: 8604819
[TBL] [Abstract][Full Text] [Related]
11. Presence of mucosal change in the urinary bladder in nonhematuric patients with long-term exposure and/or accumulating high-dose cyclophosphamide. Possible significance of follow-up cystoscopy on preventing development of cyclophosphamide-induced hemorrhagic cystitis.
Kimura M; Tomita Y; Morishita H; Takahashi K
Urol Int; 1998 Oct; 61(1):8-11. PubMed ID: 9792975
[TBL] [Abstract][Full Text] [Related]
12. Fatal hemorrhagic cystitis induced by pelvic irradiation and cyclophosphamide therapy. Case reports and review.
Price WE; Keldahl LR
Minn Med; 1990 May; 73(5):39-41, 44. PubMed ID: 2113164
[TBL] [Abstract][Full Text] [Related]
13. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.
Plotz PH; Klippel JH; Decker JL; Grauman D; Wolff B; Brown BC; Rutt G
Ann Intern Med; 1979 Aug; 91(2):221-3. PubMed ID: 464465
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the bladder complicating cyclophosphamide therapy.
Ansell ID; Castro JE
Br J Urol; 1975 Aug; 47(4):413-8. PubMed ID: 1180990
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases.
Tanguay C; Harvey I; Houde M; Srigley JR; Têtu B
Mod Pathol; 2003 May; 16(5):512-4. PubMed ID: 12748258
[TBL] [Abstract][Full Text] [Related]
16. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.
Cannon J; Linke CA; Cos LR
Urology; 1991 Nov; 38(5):413-6. PubMed ID: 1949449
[TBL] [Abstract][Full Text] [Related]
18. [Endoxan hemorrhage from the bladder. Sterile hemorrhagic cystitis caused by cyclophosphamide].
Pauwels RP; Moonen WA; Janknegt RA
Ned Tijdschr Geneeskd; 1969 Oct; 113(43):1883-8. PubMed ID: 5345768
[No Abstract] [Full Text] [Related]
19. Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment.
Souza AWS; Dantas JG; Montandon ACOES; Calich AL; Mont' Alverne ARS; Gasparin AA; Bianchi D; Yuki EFN; Sacilotto N; Dos Reis Neto ET; Monticielo OA; Pereira IA
Adv Rheumatol; 2024 May; 64(1):41. PubMed ID: 38773538
[TBL] [Abstract][Full Text] [Related]
20. [Urothelial cancers from Endoxan].
Dumas JP; Roulet B; Colombeau P; Loubet R
J Urol (Paris); 1984; 90(6):411-2. PubMed ID: 6520414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
